Eugene Potesta, MD
Otolaryngology · Youngstown, OHNPI 1316032097
Payments from drug & device makers
Across 110 payments — averaging $39.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$700
- GSK$639
- Integra Lifesciences Corporation$502
- Davol Inc.$356
- Acclarent, Inc$327
- Advanced Bionics, LLC$269
- plus $2K from 14 others
What the payments were for
- Food & beverage$4,26398%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 19 | $700 |
| GSK | 39 | $639 |
| Integra Lifesciences Corporation | 6 | $502 |
| Davol Inc. | 3 | $356 |
| Acclarent, Inc | 8 | $327 |
| Advanced Bionics, LLC | 2 | $269 |
| Intersect ENT, Inc. | 4 | $223 |
| Inspire Medical Systems, Inc. | 3 | $212 |
| Optinose US, Inc. | 8 | $193 |
| Medtronic(2 entities) | 2 | $149 |
| Stryker | 5 | $147 |
| Cochlear Americas | 2 | $119 |
| Kerecis Limited | 1 | $116 |
| Checkpoint Surgical, Inc | 1 | $115 |
| Axogen | 1 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $68 |
| Smith+Nephew | 2 | $38 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Johnson & Johnson | 1 | $28 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$464
- INTEGRA$401
- HIRES ULTRA CI HIFOCUS MS ELECTRODE$269
- PROGEL$223
- PROPEL$138
- INTEGRA DERMAL REGENERATION TEMPLATE$134
- PRIMATRIX$134
- ARISTA$133
- DUPIXENT$123
- Acclarent Aera$119
- Kerecis GraftGuide$116
- Checkpoint Stimulators$115
- NUCALA$113
- Inspire$108
How this compares
$4,331 in reported general payments places this provider in the 80th percentile of 380 otolaryngology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 46 | $2,322 |
| Azelastine Hcl | 102 | $1,847 |
| Ofloxacin | 45 | $1,714 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 17 | $1,478 |
| Fluticasone Propionate | 101 | $972 |
| Ipratropium Bromide | 32 | $680 |
| Mometasone Furoate | 44 | $555 |
| Montelukast Sodium | 66 | $458 |
| Cefdinir | 32 | $416 |
| Mupirocin | 35 | $189 |
| Methylprednisolone | 23 | $171 |
| Cephalexin | 20 | $115 |
| Azithromycin | 27 | $88 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $79 |
| Prednisone | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Youngstown
- Oliver AdunkaColumbus$1M
- Raj SindwaniCleveland$626K
- Mark MehleCleveland$403K
- Cameron WickCleveland$401K
- Troy WoodardCleveland$392K
- Ahmad SedaghatCincinnati$270K
- Eugene ChioColumbus$247K
- Subinoy DasColumbus$142K
- Katie PhillipsCincinnati$137K
- Sanjeet RangarajanCleveland$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.